CECreative Medical Technology Holdings, Inc. CELZ · NASDAQ
$0.74 -4.39% (-$0.03)
- Market cap
- $1.87M
- Enterprise value
- -$6.85M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 622.5x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -71.9%
- Gross margin
- -1,732.4%
- Net margin
- -201,355.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.91
- Free float
- 92.4%
About the company
Creative Medical Technology Holdings, Inc. (CELZ) shares could be suitable for investors looking to invest in the biotechnology and regenerative medicine sector. The company's focus on research and development of therapeutic solutions for the treatment of various diseases positions it as a key player in the field of biotechnology and regenerative medicine. Known for its efforts to harness modern technologies to support tissue self-regeneration and treat chronic illnesses, Creative Medical Technology Holdings, Inc. aims to provide innovative treatment options and enhance the quality of life for patients.
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy Warbington
Employees
4
Headquarters
Phoenix
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number